Bergfelt L
Department of Dermatology, University of Göteborg, Sweden.
Acta Derm Venereol Suppl (Stockh). 1993;180:1-37.
The epidermal Langerhans cell (LC) plays an important role in contact hypersensitivity reactions by presenting the antigens to T lymphocytes. LCs may also play a role in defence mechanisms against neo-antigens in skin tumours. Some studies have indicated that the LC population declines with age. Ultraviolet radiation induces a significant reduction in the number of epidermal LCs and most immunosuppressive drugs decrease the number and function of LCs as well. Such alterations in LCs might predispose to the development of skin tumours. To evaluate the importance of LCs in immunosurveillance of skin tumours, the number and the morphology of LCs was investigated in unaffected skin of patients with cutaneous tumours and in immunosuppressed patients. LCs within basal cell carcinoma (BCC) were examined as well. ATPase and CD1a staining was used to visualise LCs. The inflammatory response around BCC was estimated by the expression of HLA-DR+, CD3+ and ICAM-1+ cells. The prevalence of skin tumours was studied in renal transplant recipients on different immunosuppressive treatments such as azathioprine (Aza) and prednisolone (P), cyclosporin (CyA), azathioprine and prednisolone or cyclosporin and prednisolone. We found no difference in LC populations in patients treated with PUVA (psoralen and UVA-radiation) or in patients with skin tumours as compared with controls and no age-related reduction in LC numbers. However, immunosuppressed patients showed a reduced number of LCs, especially those who had received triple drug therapy (CyA+Aza+P). Patients treated with azathioprine and prednisolone (10-25 years) had a high prevalence of multiple warts (40%) and skin tumours (29%). In contrast, warts and skin tumours were not common in patients treated for 5 years with CyA+Aza+P or with CyA+P. Thus, the duration of immunosuppressive treatment seems crucial for the development of warts and skin tumours. However, the reduction in LC numbers was not more pronounced with time or in patients with skin lesions as compared with those without lesions. In the epidermis overlying basal cell carcinoma (BCC) the number of LCs was decreased and their morphology changed as compared with LCs in perilesional skin. These alterations were documented in horizontal sheets as well as in vertical sections of the epidermis analysed by light microscopy and with confocal laser scanning microscopy (CLSM). The latter technique permits a quantitative and morphological analysis of LCs in the same tissue volume. In vertical sections, numerous LCs were observed in the dermis surrounding BCC nests.(ABSTRACT TRUNCATED AT 400 WORDS)
表皮朗格汉斯细胞(LC)通过将抗原呈递给T淋巴细胞,在接触性超敏反应中发挥重要作用。LC在抵御皮肤肿瘤新抗原的防御机制中可能也发挥作用。一些研究表明,LC数量会随着年龄增长而减少。紫外线辐射会导致表皮LC数量显著减少,大多数免疫抑制药物也会降低LC的数量和功能。LC的这些改变可能易引发皮肤肿瘤。为评估LC在皮肤肿瘤免疫监视中的重要性,我们对皮肤肿瘤患者的未受影响皮肤以及免疫抑制患者的LC数量和形态进行了研究。同时也检查了基底细胞癌(BCC)内的LC。采用ATP酶和CD1a染色来观察LC。通过HLA-DR +、CD3 +和ICAM-1 +细胞的表达来评估BCC周围的炎症反应。研究了接受不同免疫抑制治疗(如硫唑嘌呤(Aza)和泼尼松龙(P)、环孢素(CyA)、硫唑嘌呤和泼尼松龙或环孢素和泼尼松龙)的肾移植受者中皮肤肿瘤的患病率。我们发现,与对照组相比,接受补骨脂素和紫外线A辐射(PUVA)治疗的患者或患有皮肤肿瘤的患者的LC数量没有差异,且LC数量也没有与年龄相关的减少。然而,免疫抑制患者的LC数量减少,尤其是那些接受三联药物治疗(CyA + Aza + P)的患者。接受硫唑嘌呤和泼尼松龙治疗(10 - 25年)的患者多发性疣(40%)和皮肤肿瘤(29%)的患病率较高。相比之下,接受CyA + Aza + P或CyA + P治疗5年的患者中,疣和皮肤肿瘤并不常见。因此,免疫抑制治疗的持续时间似乎对疣和皮肤肿瘤的发生至关重要。然而,与无皮肤病变的患者相比,LC数量的减少在有皮肤病变的患者中或随着时间推移并没有更明显。在基底细胞癌(BCC)上方的表皮中,与病变周围皮肤中的LC相比,LC数量减少且形态发生改变。这些改变在通过光学显微镜和共聚焦激光扫描显微镜(CLSM)分析的表皮水平切片以及垂直切片中均有记录。后一种技术允许对相同组织体积内的LC进行定量和形态分析。在垂直切片中,在BCC巢周围的真皮中观察到大量LC。(摘要截断于400字)